Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
Francesco Paolo Cantatore,1 Nicola Maruotti,1 Addolorata Corrado,1 Domenico Ribatti2,3 1Rheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia Medical School, Foggia, 2Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical S...
Saved in:
Main Authors: | Cantatore FP, Maruotti N, Corrado A, Ribatti D |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/befd641cc2d2455daf343cfa3022d61f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Features of heritable disorders of connective tissue in children with acute rheumatic fever and rheumatic heart disease
by: Oksana Boyarchuk
Published: (2020) -
Liver involvement in rheumatic diseases
by: Joanna Podgórska, et al.
Published: (2020) -
COMPLEXITY OF EARLY DIAGNOSIS AND TREATMENT OF RHEUMATIC DISEASES
by: M. V. Sklyanova, et al.
Published: (2012) -
The challenge of screening for asymptomatic rheumatic heart disease in South Africa
by: Liesl Zühlke, et al.
Published: (2017) -
Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases
by: Kalliopi Klavdianou, et al.
Published: (2021)